N-chlorinated Cationic Compounds for Selective Antimicrobial Action
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current N-halogenated and N,N-dihalogenated compounds used as antimicrobial agents often exhibit toxicity to mammalian cells, limiting their therapeutic applications due to their broad disinfectant properties.
Innovation Solution
Development of specific compounds represented by Formula I, which include various N-halogenated and N,N-dihalogenated structures with improved antimicrobial efficacy while minimizing toxicity, suitable for use as antibacterial, anti-infective, disinfectant, antifungal, and antiviral agents, along with methods for their preparation and application in treating microbial infections and disinfecting surfaces and medical devices.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If chlorinating agents are used as antimicrobial agents, then antimicrobial efficacy is improved, but toxicity to mammalian cells increases
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of N-halogenated compounds through specific substituents (A1, A2, R1, R2, R3 groups) and halogenation patterns to alter the balance between antimicrobial efficacy and mammalian cell toxicity. By systematically varying these chemical parameters, the invention achieves compounds with improved therapeutic index.
Solution Approach 2:
The patent employs local quality by introducing specific functional groups and substituents at particular positions in the molecular structure (indicated by the detailed variable definitions in Formula I). This localized modification of molecular regions allows selective enhancement of antimicrobial activity while minimizing toxicity to mammalian cells.
2Adaptability or versatility
If broad-spectrum disinfectant properties are achieved, then antimicrobial coverage is improved, but selectivity against mammalian cells deteriorates
Solution Approach 1:
The patent uses parameter changes to achieve broad-spectrum antimicrobial activity while maintaining selectivity. The detailed structural parameters (n, m, Z1, Z2, Y, X, A1, A2, R1, R2, R3) provide multiple degrees of freedom for optimizing the compound's interaction with different microbial targets while preserving mammalian cell selectivity.
Solution Approach 2:
The patent achieves universality by designing compounds with broad-spectrum antimicrobial activity against bacteria, fungi, and viruses while simultaneously maintaining selectivity for microbial targets over mammalian cells. The versatile molecular framework can target multiple types of microorganisms through different mechanisms.
Data Source
AI summary
The present application relates to N-chlorinated cationic compounds of Formula Ior a salt thereof, and associated compositions and methods of use as antimicrobial agents.